NO148454C - Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivaterInfo
- Publication number
- NO148454C NO148454C NO784382A NO784382A NO148454C NO 148454 C NO148454 C NO 148454C NO 784382 A NO784382 A NO 784382A NO 784382 A NO784382 A NO 784382A NO 148454 C NO148454 C NO 148454C
- Authority
- NO
- Norway
- Prior art keywords
- tiazolidine
- preparation
- therapeutically active
- dione derivatives
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7739559A FR2413381A1 (fr) | 1977-12-29 | 1977-12-29 | Derives de thiazolidinedione et leur application en therapeutique |
FR7833244A FR2442232A2 (fr) | 1978-11-24 | 1978-11-24 | Derives de thiazolidinedione-2,4 et leur application en therapeutique |
Publications (3)
Publication Number | Publication Date |
---|---|
NO784382L NO784382L (no) | 1979-07-02 |
NO148454B NO148454B (no) | 1983-07-04 |
NO148454C true NO148454C (no) | 1983-10-12 |
Family
ID=26220372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO784382A NO148454C (no) | 1977-12-29 | 1978-12-27 | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater |
Country Status (17)
Country | Link |
---|---|
US (1) | US4349683A (es) |
EP (1) | EP0002978B1 (es) |
JP (1) | JPS6011908B2 (es) |
AR (1) | AR223160A1 (es) |
AT (1) | AT370098B (es) |
AU (1) | AU517221B2 (es) |
CA (1) | CA1107740A (es) |
DE (1) | DE2862059D1 (es) |
DK (1) | DK149429C (es) |
ES (1) | ES476408A1 (es) |
FI (1) | FI68819C (es) |
GR (1) | GR65312B (es) |
IE (1) | IE47902B1 (es) |
IL (1) | IL56304A (es) |
NO (1) | NO148454C (es) |
NZ (1) | NZ189300A (es) |
PT (1) | PT68991A (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6610081A (en) * | 1980-01-24 | 1981-07-30 | Senju Pharmaceutical Co., Ltd. | Thiazolidine derivatives |
JPH0750560B2 (ja) * | 1981-05-09 | 1995-05-31 | ヤマハ株式会社 | ディジタル集積回路装置 |
US4367335A (en) * | 1981-08-03 | 1983-01-04 | Mead Johnson & Company | Thiazolidinylalkylene piperazine derivatives |
US4456756A (en) * | 1981-08-03 | 1984-06-26 | Mead Johnson & Company | Spirothiazolidinyl piperazine derivatives |
EP0715853A1 (en) * | 1991-01-10 | 1996-06-12 | Transcend Therapeutics, Inc. | Use of glutathione esters for the treatment of pulmonary diseases |
US5747459A (en) * | 1991-02-04 | 1998-05-05 | Nestec, Ltd. | Method for insuring adequate intracellular glutathione in tissue |
US5430045A (en) * | 1992-04-23 | 1995-07-04 | Free Radical Sciences, Inc. | Method of reducing or preventing bone marrow hypoplasia |
US5447712A (en) * | 1993-12-09 | 1995-09-05 | Free Radical Sciences | Method of reducing cyclophosphamide induced hemorrhagic cystitis |
ES2199086B1 (es) * | 2002-07-31 | 2005-06-01 | Cepa Schwarz Pharma Sl | Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas. |
KR20150068829A (ko) * | 2013-12-12 | 2015-06-22 | 삼성전자주식회사 | 알킬 암모늄염 화합물을 포함하는 유도 용질 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1435004A (fr) * | 1965-02-04 | 1966-04-15 | Sobio Lab | Dérivés de thiazolidine-dione-2, 4- et procédé de préparation |
-
1978
- 1978-12-13 EP EP78400236A patent/EP0002978B1/fr not_active Expired
- 1978-12-13 DE DE7878400236T patent/DE2862059D1/de not_active Expired
- 1978-12-26 IL IL56304A patent/IL56304A/xx unknown
- 1978-12-27 DK DK582578A patent/DK149429C/da not_active IP Right Cessation
- 1978-12-27 FI FI783995A patent/FI68819C/fi not_active IP Right Cessation
- 1978-12-27 CA CA318,655A patent/CA1107740A/en not_active Expired
- 1978-12-27 NO NO784382A patent/NO148454C/no unknown
- 1978-12-28 GR GR57988A patent/GR65312B/el unknown
- 1978-12-28 JP JP53164429A patent/JPS6011908B2/ja not_active Expired
- 1978-12-28 ES ES476408A patent/ES476408A1/es not_active Expired
- 1978-12-28 AU AU42961/78A patent/AU517221B2/en not_active Expired
- 1978-12-28 IE IE2561/78A patent/IE47902B1/en unknown
- 1978-12-28 AR AR274998A patent/AR223160A1/es active
- 1978-12-28 PT PT68991A patent/PT68991A/pt unknown
- 1978-12-29 AT AT0936678A patent/AT370098B/de not_active IP Right Cessation
-
1979
- 1979-01-04 NZ NZ189300A patent/NZ189300A/xx unknown
-
1980
- 1980-08-26 US US06/181,475 patent/US4349683A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0002978A3 (en) | 1979-07-25 |
IL56304A0 (en) | 1979-03-12 |
IE47902B1 (en) | 1984-07-25 |
ATA936678A (de) | 1982-07-15 |
FI783995A (fi) | 1979-06-30 |
FI68819C (fi) | 1985-11-11 |
JPS6011908B2 (ja) | 1985-03-28 |
US4349683A (en) | 1982-09-14 |
FI68819B (fi) | 1985-07-31 |
AR223160A1 (es) | 1981-07-31 |
DE2862059D1 (en) | 1982-11-11 |
CA1107740A (en) | 1981-08-25 |
NO784382L (no) | 1979-07-02 |
AT370098B (de) | 1983-02-25 |
DK149429C (da) | 1987-03-09 |
NZ189300A (en) | 1980-05-27 |
AU517221B2 (en) | 1981-07-16 |
DK149429B (da) | 1986-06-09 |
EP0002978B1 (fr) | 1982-10-06 |
GR65312B (en) | 1980-08-02 |
EP0002978A2 (fr) | 1979-07-11 |
DK582578A (da) | 1979-06-30 |
JPS5498758A (en) | 1979-08-03 |
ES476408A1 (es) | 1979-04-01 |
NO148454B (no) | 1983-07-04 |
IE782561L (en) | 1979-06-29 |
AU4296178A (en) | 1979-07-05 |
PT68991A (fr) | 1979-01-01 |
IL56304A (en) | 1982-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO148813C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater | |
NO149962C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater | |
NO147243C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater | |
NO148148C (no) | Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater | |
NO147450C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater | |
NO151321C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater | |
NO151463C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater | |
NO151411C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater | |
NO147562C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme xantinderivater | |
NO800881L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater | |
NO151040C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner | |
NO148777C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater | |
NO146095C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater | |
NO149065C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater | |
NO145762C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser | |
NO149313C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
NO149037C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
NO151285C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater | |
NO148454C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater | |
NO148488C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater | |
NO780743L (no) | Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner | |
NO780644L (no) | Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater | |
NO794318L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater | |
NO152556C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner | |
NO144741C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler |